Drug Topics

JUNE 20, 2023

A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.

Vaccines 446

Vaccines 446

PharmaVoice

JUNE 20, 2023

The AI revolution is bringing a new era of drug discovery, and the potential for more uses is greater and faster than ever before.

270

270

Pharmacy Times

JUNE 20, 2023

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

Adverse Reactions 156

Adverse Reactions FDA 156

PharmaVoice

JUNE 20, 2023

As the fallout of the Aduhelm approval continues, scrutiny of the speedier pathway has increased and the pressure is on to close a key gap in the regulation.

FDA 189

FDA 189

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PhRMA

JUNE 20, 2023

As technology continues to rapidly advance, it’s important for regulatory agencies like the U.S. Food and Drug Administration (FDA) to keep pace and adopt new technologies and approaches to support its public health mission and ultimately, better serve patients.

FDA 146

FDA 146

Pharmacy Times

JUNE 20, 2023

More than 4 times as many people who used the app quit smoking compared to a traditional support service.

139

139

Pharmacy Times

JUNE 20, 2023

Standard prediction models that assess an individual’s risk of developing dementia and how to prevent it are limited in their ability to do so, showing high error rates and a higher chance of receiving a false-positive result, according to a recent study.

138

138

STAT

JUNE 20, 2023

I recently took care of a patient whose medical records included multiple notes about her past open-heart surgery. Only she had never undergone open-heart surgery.

Medical Records 127

Medical Records 127

Pharmacy Times

JUNE 20, 2023

Investigators found that individuals who received metformin were approximately 40% less likely to develop long COVID than those who received a placebo.

132

132

Fierce Pharma

JUNE 20, 2023

Three weeks after the FDA warned that some pharmacies are making unauthorized versio | Novo Nordisk filed five lawsuits in four states on Tuesday, charging health spas, clinics and pharmacies with false advertising, trademark infringement and unlawful sales of compounded versions of diabetes and weight loss drugs Ozempic and Wegovy. Novo also is planning action against other unlawful sellers, the company said.

Compounding 124

Compounding FDA 124

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 20, 2023

Employers across the country — from big names like Boeing and UPS to local school systems — pay consulting firms to handle a straightforward task with their prescription drug coverage: Get the best deals possible, and make sure the industry’s middlemen, known as pharmacy benefit managers, aren’t ripping them off with unfair contracts.

Insurance 124

Insurance Documentation 124

Pharmacy Times

JUNE 20, 2023

Multivitamins were associated with increased cellular oxygen consumption and more optimal blood nutrition biomarkers.

123

123

pharmaphorum

JUNE 20, 2023

The World Without Disease: Live Coverage Mike.

121

121

Pharmacy Times

JUNE 20, 2023

The novel antibiotic combines aztreonam, a monobactam β-lactam, with avibactam, a broad-spectrum β-lactamase inhibitor.

122

122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JUNE 20, 2023

About 1,800 of Providence’s Oregon nurses and clinicians are on strike this week amid contract negotiations, prompting the health system to cut back some services at its facilities to preserve capa | Contract disagreements led 1,800 union nurses to the picket lines this week. To cope, Providence has hired replacement staff and is limiting several services and transfers at three locations: Providence Portland Medical Center, Providence Seaside Hospital and Providence Home Health and Hospice.

Hospitals 111

Hospitals 111

pharmaphorum

JUNE 20, 2023

Boehringer loses bid to be shielded from Zantac litigation Phil.

111

111

STAT

JUNE 20, 2023

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash. The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday. “In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,

106

106

pharmaphorum

JUNE 20, 2023

Survey sheds light on scale of drug shortages in UK Phil.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

JUNE 20, 2023

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and selected pharma and medical device companies have launched the European Coalition for Access to Comprehensive Genomic Profiling (ECGP), to promote the routine use of comprehensive genomic profiling. The ECGP aims to create multi-stakeholder outputs that will support wider coverage and reimbursement for genomic profiling through three key objectives.

105

105

Fierce Healthcare

JUNE 20, 2023

NYU Langone Health System is suing to block competitor Northwell Health from running ads the former said are mimicking its long-established color palettes and encroaching on its reputation. | NYU Langone Health System alleges that Northwell Health began to intentionally run similar ads in 2019 to cash in on the former's "outstanding reputation.

105

105

Fierce Pharma

JUNE 20, 2023

After Merck filed a bombshell lawsuit challenging some measures in the Inflation Reduction Act (IRA), Bristol Myers Squibb has followed on with a case of its own. | After Merck took the first legal stab at the Inflation Reduction Act with a lawsuit against the Department of Health and Human Services (HHS), Bristol Myers Squibb is the latest drugmaker to allege Constitutional violations.

104

104

Fierce Healthcare

JUNE 20, 2023

This week the Fierce newsroom took the day off to honor Juneteenth. So we've selected a few favorite segments from the fall of 2022 to reshare in this week's episode. | This week on "Podnosis," we talk about the momentum behind addressing health equity challenges. Also under discussion is how social drivers of health are finally being recognized by CMS.

105

105

Fierce Pharma

JUNE 20, 2023

Immune checkpoint inhibitors haven’t had tons of success in stomach cancer. Now, Merck has added one failure to the mix. | Immune checkpoint inhibitors haven’t had tons of success in stomach cancer. Now, Merck has added one failure to the mix.

Immunization 103

Immunization 103

The Checkup by Singlecare

JUNE 20, 2023

It might seem odd that ingesting live microorganisms—essentially, germs—can be good for your health, but that’s the idea behind probiotics. Probiotics have become a popular supplement for people searching for better gut health and improved overall health. But not everyone should take probiotics. They can cause unwanted side effects, such as bloating, gas, or constipation.

Immunization 98

Immunization Adverse Reactions Chemotherapy Compounding 98

Pharmaceutical Technology

JUNE 20, 2023

Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed an exclusive licence and collaboration deal for Santhera’s vamorolone in the US, Canada and Mexico. Catalyst Pharmaceuticals will gain exclusive rights to commercialise vamorolone across the region. The investigational drug candidate vamorolone has a mode of action based on binding to the same receptor as glucocorticoids while changing its downstream activity.

FDA 98

FDA 98

STAT

JUNE 20, 2023

In the latest fracas over obesity drugs , Novo Nordisk filed lawsuits alleging several medical spas, wellness clinics, and weight loss clinics around the U.S. are illegally selling compounded versions of its medicines. The drugmaker accused the businesses of false advertising, unfair competition, and infringing on trademarks for three medicines: Wegovy, Ozempic, and Rybelsus.

Compounding 98

Compounding 98

The Checkup by Singlecare

JUNE 20, 2023

If you have diverticulosis , a.k.a. small pockets inside the lining of your colon, there’s a chance you’ve experienced diverticulitis, or the inflammation and infection of one of those pockets. Diverticulosis is relatively common, affecting around 50% of people over 60 , though it often doesn’t cause symptoms, and people may not know they have it. Diverticulitis, on the other hand, is less common but more problematic.

Hospitals 98

Hospitals 98

STAT

JUNE 20, 2023

Rise and shine, everyone, another busy day is on the way. We can tell by the number of people walking past and cars whizzing by the Pharmalot campus this morning. These are among our usual proxies for gauging the state of the world outside our window. All of this is to say there is much to do. So time to get cracking. We are firing up the coffee kettle and brewing a cup of stimulation — salted caramel mocha is the choice right now — and digging out the to-do list.

Insurance 98

Insurance 98

Fierce Healthcare

JUNE 20, 2023

Healthcare startup Equip has tapped former Get Well executive Nikia Bergan as its first-ever president to shepherd the company through its next growth phase. | Healthcare startup Equip has tapped former Get Well executive Nikia Bergan as its first-ever president to shepherd the company through its next growth phase.

98

98

STAT

JUNE 20, 2023

WASHINGTON — The FDA wants to make it easier for consumers to know if the foods they’re buying are unhealthy — but doing so is harder than it seems here in the United States. Much of the Americas already has so-called front of package labels — small symbols printed on packaged foods that alert consumers when a food is high in certain unhealthy nutrients like sodium or saturated fat.

Packaging 98

Packaging Labelling Grocery Stores FDA 98

Pharmaceutical Technology

JUNE 20, 2023

Netherlands-based immunology company argenx has announced plans to advance to a second dose cohort in the Phase II ARDA study (NCT05225675) evaluating its antibody empasiprubart (ARGX-117) in multifocal motor neuropathy (MMN). This comes after an independent data monitoring committee confirmed the safety and tolerability profile of ARGX-117 was consistent with results from an earlier Phase I study.

Immunization 98

Immunization Communication 98

pharmaphorum

JUNE 20, 2023

Catalyst throws lifeline to Santhera with $90m Duchenne deal Phil.

98

98

STAT

JUNE 20, 2023

WASHINGTON — The top federal lobbyist for the brand drug lobby PhRMA is leaving, two drug industry lobbyists and one health care lobbyist told STAT on Tuesday. Anne Esposito, who was the trade group’s senior vice president for federal advocacy, played an important role in shaping PhRMA’s lobbying strategy over her three and a half years at the organization.

98

98